Donghui Zhang

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Dual-Target Cardiac Regeneration: Controllable Nfyb/Nr3c1 Cointervention Spurs Cardiomyocyte Cytokinesis After Myocardial Infarction.

Dual-Target Cardiac Regeneration: Controllable Nfyb/Nr3c1 Cointervention Spurs Cardiomyocyte Cytokinesis After Myocardial Infarction.

Journal: Circulation
Published: August 25, 2026

Modeling calcific aortic valve disease with engineered human valve tissues identifies SAMHD1 as a therapeutic target.

Modeling calcific aortic valve disease with engineered human valve tissues identifies SAMHD1 as a therapeutic target.

Journal: Biomaterials
Published: March 04, 2026

Direct Therapeutic Modulation of RYR2 Activity by CMYA5.

Direct Therapeutic Modulation of RYR2 Activity by CMYA5.

Journal: Circulation
Published: October 20, 2025

Injectable hydrogel bioelectrostimulator for wireless deep brain neuromodulation.

Injectable hydrogel bioelectrostimulator for wireless deep brain neuromodulation.

Journal: Nature communications
Published: September 01, 2025

Multi-nozzle bioprinting of biomimetic tissue models with mechanical reinforcement and bioactive matrix remodeling.

Multi-nozzle bioprinting of biomimetic tissue models with mechanical reinforcement and bioactive matrix remodeling.

Journal: Biofabrication
Published: September 01, 2025

HDAC2-mediated recruitment of METTL3 to chromatin regulates human embryonic stem cell differentiation.

HDAC2-mediated recruitment of METTL3 to chromatin regulates human embryonic stem cell differentiation.

Journal: Cell reports
Published: May 21, 2025

Soluble ST2 drives fulminant myocarditis progression via the IGF2R-YY1 mitochondrial axis.

Soluble ST2 drives fulminant myocarditis progression via the IGF2R-YY1 mitochondrial axis.

Journal: European heart journal
Published: April 28, 2025

A Human Engineered Heart Tissue-Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin.

A Human Engineered Heart Tissue-Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 19, 2025

Neural Organoids Protect Engineered Heart Tissues From Glucolipotoxicity by Transferring Versican in a Co-Culture System.

Neural Organoids Protect Engineered Heart Tissues From Glucolipotoxicity by Transferring Versican in a Co-Culture System.

Journal: Cell proliferation
Published: February 05, 2025

Long noncoding RNA as an emerging regulator of endoderm differentiation: progress and perspectives.

Long noncoding RNA as an emerging regulator of endoderm differentiation: progress and perspectives.

Journal: Cell regeneration (London, England)
Published: December 10, 2024

Ribo-seq provides additional evidence for cytoplasm-translated mitochondrial DNA-encoded ORFs.

Ribo-seq provides additional evidence for cytoplasm-translated mitochondrial DNA-encoded ORFs.

Journal: Science China. Life sciences
Published: November 18, 2024

Protocol for differentiating cardiomyocytes and generating engineered heart tissues from human feeder-free extended pluripotent stem cells.

Protocol for differentiating cardiomyocytes and generating engineered heart tissues from human feeder-free extended pluripotent stem cells.

Journal: STAR protocols
Published: October 24, 2024
Showing 1-12 of 56

Last Updated: 09/26/2026